05.09.26 -- Bioprocess Online - Best Of April

The FDA issued a total of 303 warning letters to drug and biologics products in Fiscal Year 2025 (FY25), an increase from FY24. This article reveals key agency focal points and trends.

In this segment from the Bioprocess Online Live event, our panelists discuss the challenges development teams face when upstream and downstream teams operate concurrently in a vacuum.

This interactive panel discussion explored how upstream and downstream development teams can work together to reduce risk, accelerate process scaling, and support smoother downstream tech transfer.

Learn five essential best practices to maintain a sterile incubator shaker environment, from routine cleaning and humidity control to advanced HEPA filtration for reliable results.

Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

Digital PCR enables fast mycoplasma detection in cell-based products. Find out how this pharmacopeia-compliant workflow improves accuracy, reduces delays, and supports reliable decision-making.